TITLE

Coeliac disease: in vivo toxicity of the putative immunodominant epitope

AUTHOR(S)
Fraser, J. S.; Engel, W.; Ellis, H. J.; Moodie, S. J.; Pollock, E. L.; Wieser, H.; Ciclitira, P. J.
PUB. DATE
December 2003
SOURCE
Gut;Dec2003, Vol. 52 Issue 12, p1698
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Peptides from α-gliadins have been used to characterise the immunodominant coeliac toxic epitope. A peptide corresponding to amino acid residues 57-73 of A-gliadin causes peripheral blood mononuclear cells from coeliac patients to secrete interferon γ (IFN-γ); gluten specific small intestinal T cell clones proliferate in response to peptides corresponding to residues 57-68 and 62-75 of α-gliadins. We wished to investigate whether a peptide corresponding to residues 56-75 of α-gliadins exacerbates coeliac disease in vivo. Methods: Four adults with coeliac disease, all of whom were on a gluten free diet, underwent three challenges. Peptic-tryptic gliadin (PTG 1 g) served as a positive control. The test peptide and a negative control peptide were studied on separate occasions. The peptides were instilled into the duodenum and biopsies were taken before the infusion, and two, four, and six hours after commencing the infusions, using a Quinton hydraulic multiple biopsy capsule. Biopsy specimens were assessed blindly for villus height to crypt depth ratio (VH:CD), enterocyte cell height (ECH), and intraepithelial lymphocyte (IEL) count. We used the Mann-Whitney U test, with 95% confidence intervals, for statistical analysis. Results: VH:CD and ECH fell, and IEL increased significantly 4-6 hours after commencing infusions with both PIG and the test peptide in all subjects. The negative control peptide caused no significant changes to villus morphology, enterocyte height, or IEL count in any patient. Conclusion: We have confirmed that the putative immunodominant epitope, a peptide corresponding to residues 56-75 of α-gliadins, exacerbates coeliac disease in vivo.
ACCESSION #
12940906

 

Related Articles

  • Citrulina plasmática como marcador de pérdida de masa enterocitaria en la enfermedad celíaca en la infancia. Blasco Alonso, J.; Serrano Nieto, J.; Navas López, V. M.; Barco Gálvez, A.; Vicioso, I.; Carazo Gallego, B.; Ortiz Pérez, P.; Sierra Salinas, C. // Nutricion Hospitalaria;jul/ago2011, Vol. 26 Issue 4, p807 

    Introduction: Plasma citrulline is not incorporated in endogenous or exogenous proteins so it is a theoretical marker of villous atrophy. Our aim was to correlate plasma citrulline levels with severity of villous atrophy in celiac patients. Methods: Observational case-control study longitudinal...

  • Molecular Characterization and Evolutionary Analysis of α-gliadin Genes from Eremopyrum bonaepartis (Triticeae). Guangrong Li; Tao Zhang; Yirong Ban; Zujun Yang // Journal of Agricultural Science (1916-9752);Dec2010, Vol. 2 Issue 4, p30 

    Total 16 α-gliadin gene sequences ranged from 1186 to 131 6bp were isolated from Eremopyrum bonaepartis by PCR based strategy. Analysis of deduced amino acid sequences indicated that 8 of 16 sequences displayed the typical structure of a-gliadin genes with six cysteine residues, while the...

  • A Universal Approach to Eliminate Antigenic Properties of Alpha-Gliadin Peptides in Celiac Disease. Mitea, Cristina; Salentijn, Elma M. J.; van Veelen, Peter; Goryunova, Svetlana V.; van der Meer, Ingrid M.; van den Broeck, Hetty C.; Mujico, Jorge R.; Monserrat, Veronica; Gilissen, Luud J. W. J.; Drijfhout, Jan Wouter; Dekking, Liesbeth; Koning, Frits; Smulders, Marinus J. M. // PLoS ONE;2010, Vol. 5 Issue 12, p1 

    Celiac disease is caused by an uncontrolled immune response to gluten, a heterogeneous mixture of wheat storage proteins, including the α-gliadins. It has been shown that α-gliadins harbor several major epitopes involved in the disease pathogenesis. A major step towards elimination of...

  • A novel and sensitive method for the detection of T cell stimulatory epitopes of &alph;/β- and γ-gliadin. Spaenij-Dekking, E. H. A.; Kooy-Winkelaar, E. M. C.; Nieuwenhuizen, W. F.; Drijfhout, J. W.; Koning, F. // Gut;Sep2004, Vol. 53 Issue 9, p1267 

    Background: It is now generally accepted that coeliac disease (CD) is caused by inflammatory T cell responses to gluten peptides bound to HLA-DQ2 or -DQ8 molecules. There is overwhelming evidence that CD patients can mount T cell responses to peptides found in both α-gliadin and γ-gliadin...

  • Determination of B-Cell Epitopes in Patients with Celiac Disease: Peptide Microarrays. Choung, Rok Seon; Marietta, Eric V.; Van Dyke, Carol T.; Brantner, Tricia L.; Rajasekaran, John; Pasricha, Pankaj J.; Wang, Tianhao; Bei, Kang; Krishna, Karthik; Krishnamurthy, Hari K.; Snyder, Melissa R.; Jayaraman, Vasanth; Murray, Joseph A. // PLoS ONE;1/29/2016, Vol. 11 Issue 1, p1 

    Background: Most antibodies recognize conformational or discontinuous epitopes that have a specific 3-dimensional shape; however, determination of discontinuous B-cell epitopes is a major challenge in bioscience. Moreover, the current methods for identifying peptide epitopes often involve...

  • HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease. Tollefsen, Stig; Arentz-Hansen, Helene; Fleckenstein, Burkhard; Molberg, Øyvind; Ráki, Melinda; Kwok, William W.; Jung, Günther; Lundin, Knut E. A.; Sollid, Ludvig M. // Journal of Clinical Investigation;Aug2006, Vol. 116 Issue 8, p2226 

    Celiac disease is associated with HLA-DQ2 and, to a lesser extent, HLA-DQ8. Type 1 diabetes is associated with the same DQ molecules in the opposite order and with possible involvement of trans-encoded DQ heterodimers. T cells that are reactive with gluten peptides deamidated by transglutaminase...

  • In silico characterization of immunogenic epitopes presented by HLA-Cw*0401. Joo Chuan Tong; Zong Hong Zhang; August, J. Thomas; Brusic, Vladimir; Tin Wee Tan; Ranganathan, Shoba // Immunome Research;2007, Vol. 3, p1 

    Background: HLA-C locus products are poorly understood in part due to their low expression at the cell surface. Recent data indicate that these molecules serve as major restriction elements for human immunodeficiency virus type 1 (HIV-1) cytotoxic T lymphocyte (CTL) epitopes. We report here a...

  • OETMAP: a new feature encoding scheme for MHC class I binding prediction. Gök, Murat; Özcerit, Ahmet // Molecular & Cellular Biochemistry;Jan2012, Vol. 359 Issue 1/2, p67 

    Deciphering the understanding of T cell epitopes is critical for vaccine development. As recognition of specific peptides bound to Major histocompatibility complex (MHC) class I molecules, cytotoxic T cells are activated. This is the major step to initiate of immune system response. Knowledge of...

  • Development of a Novel In Silico Docking Simulation Model for the Fine HIV-1 Cytotoxic T Lymphocyte Epitope Mapping. Mori, Masahiko; Matsuki, Kei; Maekawa, Tomoyuki; Tanaka, Mari; Sriwanthana, Busarawan; Yokoyama, Masaru; Ariyoshi, Koya // PLoS ONE;Jul2012, Vol. 7 Issue 7, p1 

    Introduction: Class I HLA's polymorphism has hampered CTL epitope mapping with laborious experiments. Objectives are 1) to evaluate the novel in silico model in predicting previously reported epitopes in comparison with existing program, and 2) to apply the model to predict optimal epitopes with...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics